Evaxion A (EVAX) Assets Average (2021 - 2026)
Evaxion A posted quarterly Assets Average of $26.0 million for Q1 2026, up 37.98% year-on-year from $18.9 million in Q1 2025, and down 10.48% on a QoQ basis from $29.1 million in Q4 2025.
Evaxion A (EVAX) has 6 years of Assets Average data on file, last reported at $26.0 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 37.98% year-over-year to $26.0 million; the trailing twelve-month figure through Mar 2026 stood at $26.0 million (up 37.98% YoY), and the FY2025 full-year result was $20.4 million, up 61.16% from the prior year.
- Assets Average for Q1 2026 stood at $26.0 million, down from $29.1 million in the prior quarter.
- Across five years, Assets Average topped out at $40.6 million in Q1 2022 and bottomed at $6.5 million in Q1 2024.
- The 5-year median for Assets Average is $23.8 million (2025), against an average of $22.5 million.
- The widest annual swing landed in 2024, when Assets Average sank 69.63%; it then surged 212.63% in 2025.
- A 5-year view of Assets Average shows it stood at $24.7 million in 2022, then sank by 49.81% to $12.4 million in 2023, then slumped by 38.57% to $7.6 million in 2024, then jumped by 281.19% to $29.1 million in 2025, then decreased by 10.48% to $26.0 million in 2026.
- The last three Assets Average figures came in at $26.0 million (Q1 2026), $29.1 million (Q4 2025), and $26.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 2.30 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.03 Mn |
| Dec 31, 2025 | 29.07 Mn |
| Sep 30, 2025 | 26.09 Mn |
| Jun 30, 2025 | 23.84 Mn |
| Mar 31, 2025 | 18.86 Mn |
| Jun 30, 2024 | 7.63 Mn |
| Mar 31, 2024 | 6.46 Mn |
| Dec 31, 2023 | 12.42 Mn |
| Sep 30, 2023 | 14.35 Mn |
| Jun 30, 2023 | 18.62 Mn |
| Mar 31, 2023 | 21.26 Mn |
| Dec 31, 2022 | 24.74 Mn |
| Sep 30, 2022 | 30.73 Mn |
| Jun 30, 2022 | 37.54 Mn |
| Mar 31, 2022 | 40.62 Mn |
| Dec 31, 2021 | 32.14 Mn |
| Sep 30, 2021 | 25.89 Mn |
| Jun 30, 2021 | 31.29 Mn |
| Mar 31, 2021 | 23.44 Mn |